INDISA.SN Inst Diagnosti

Healthcare Health Care Providers & Services Chilean Stock Exchange
2,340 CLP
Close of Oct 29, 2026
Market cap
CLP 364B
P/E
29.2x
P/B
1.68x
ROE
3.6%
Dividend yield
0.60%
Fundamental score
2.3/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is INDISA.SN undervalued?

Graham number
Price2,340
Graham value1,588
Premium47.4%

INDISA.SN trades 47.4% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Inst Diagnosti fundamental analysis

10 of 22 checks passed

ROE 0/2

Low return on equity (3.6%), below 10%.

ROA 0/1

Return on assets (1.8%) is below the industry median (2.7%).

Profit Consistency 2/2

Profitable for 10 consecutive years.

Earnings Growth 5Y 1/1

Earnings per share grew over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (103.3%) is above the 5-year average (32.3% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (103.3%) is above the industry median (1.4%).

Revenue Growth 2/2

Revenue grew 12.5% a year over the past 3 years.

Short-term Liquidity 0/1

Current assets do not cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (28.9%), 40% or less.

Debt Trend 1/1

Debt to equity has not risen over the past 5 years.

Debt Coverage 0/1

Operating cash flow does not cover 20% of total debt.

Interest Coverage 0/1

EBIT is 2.4x against interest expense, below 5x.

PE vs Market 0/1

PE (29.2x) is above the market median (13.0x).

PE vs Industry 0/1

PE (29.2x) is above the industry median (22.9x).

PBV 0/1

Price to book (1.7x) is above the industry median (1.4x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 48.9, limit 22.5).

PEG 1/1

PEG on 5-year earnings growth is 0.90, growth is cheap.

Dividend Yield 0/2

Dividend yield (0.6%) is in the bottom 25% of dividend payers in the market.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 1/1

Payout ratio is 13.9%, covered by earnings.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

About Inst Diagnosti

Instituto de Diagnóstico S.A. provides health services in Chile. It offers patient information and exams instruction, and online services; specialties services; and outpatient services including urgency, laboratory, imaging, vaccination, blood bank, outpatient procedures, and reproductive medicine unit. The company also provides hospitalization services, such as maternity, adult and pediatric hospitalization, adult critical patient unit, pavilion and surgical procedures, neo…

Full company profile